- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02907970
Perceived Barriers of Cervical Cancer Screening in Reunion Island and Key Levers for Improvment (FOSFORE)
September 4, 2018 updated by: Centre Hospitalier Universitaire de la Réunion
Identification Des barrières au dépistage du Cancer du Col utérin à la Réunion et Des Leviers d'amélioration
FOSFORE study aims at identifying the barriers of cervical cancer screening in Reunion Island and key levers for improvment.
Study Overview
Status
Completed
Conditions
Detailed Description
FOSFORE is a cross sectional KABP (Knowledge, Attitudes, Beliefs and Practices) telephone survey on cervical cancer screening from a sounding board of women aged between 25 and 65 years and living in Reunion Island.
Sample size was estimated from local datas on cervical cancer screening.
Study Type
Observational
Enrollment (Actual)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Saint Pierre, France, 97448
- Centre Universitaire de La Réunion
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Telephone survey from a sounding board of women living in Reunion Island
Description
Inclusion Criteria:
- Women aged between 25 and 65 yo
- living in Reunion Island
- speaking French, Creole or Shimaore language
- able to answer phone
Exclusion Criteria:
- history of hysterectomy
- history of incomplete or total conisation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Type of barriers in cervical cancer screening
Time Frame: 6 months
|
Telephone survey with a KABP-like questionnaire
|
6 months
|
Proportion of barriers in cervical cancer screening
Time Frame: 6 months
|
Telephone survey with a KABP-like questionnaire
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Type of levers in cervical cancer screening
Time Frame: 6 months
|
Telephone survey with a KABP-like questionnaire
|
6 months
|
Proportion of levers in cervical cancer screening
Time Frame: 6 months
|
Telephone survey with a KABP-like questionnaire
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 20, 2017
Primary Completion (Actual)
June 30, 2017
Study Completion (Actual)
June 30, 2017
Study Registration Dates
First Submitted
September 9, 2016
First Submitted That Met QC Criteria
September 16, 2016
First Posted (Estimate)
September 20, 2016
Study Record Updates
Last Update Posted (Actual)
September 5, 2018
Last Update Submitted That Met QC Criteria
September 4, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014/CHU/FOSFORE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uterine Cervical Neoplasms
-
Huazhong University of Science and TechnologyChongqing University Cancer Hospital; Peking University People's Hospital; Qilu... and other collaboratorsRecruitingCervical Cancer | Uterine Cervical Cancer | Uterine Cervical NeoplasmChina
-
Huazhong University of Science and TechnologyUnknownCervical Cancer | Uterine Cervical Cancer | Uterine Cervical NeoplasmChina
-
Huazhong University of Science and TechnologyQilu Hospital of Shandong University; Third Military Medical University; Women... and other collaboratorsRecruitingCervical Cancer | Uterine Cervical Cancer | Uterine Cervical NeoplasmChina
-
University of AarhusRecruitingUterine Cervical Neoplasm | Mass Screening | Uterine Cervical Disease | Uterine NeoplasmDenmark
-
Huazhong University of Science and TechnologyZhejiang University; Wuhan Central HospitalUnknownCervical Cancer | Uterine Cervical Neoplasms | Uterine Cervical CancerChina
-
Washington University School of MedicineTerminatedCervical Cancer | Uterine Cervical Neoplasms | Uterine Cervical CancerUnited States
-
Huazhong University of Science and TechnologyShandong University; Zhejiang UniversityCompletedCervical Cancer | Uterine Cervical Neoplasms | Uterine Cervical CancerChina
-
Center Eugene MarquisCompleted
-
University Hospitals Cleveland Medical CenterCompletedUterine Cervical Dysplasia | Uterine Cervical Cancer | Uterine Cervical Neoplasia | Uterine Cervical Intraepithelial Neoplasia
-
Siriwan Tangjitgamol, MDPrince of Songkla University; National Research Council of Thailand; Chiang Mai... and other collaboratorsUnknownUterine Cervical CancerThailand